Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucose control guidelines: current concepts.

J G Barranco1

  • 1Department of Endocrinology, National Institute of Nutrition SZ, Vasco de Quiroga No. 15, Mexico City ZC 14000.

Clinical Nutrition (Edinburgh, Scotland)
|April 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Dietary modulation of metabo-proteomic reprogramming by the EAT-lancet diet attenuates colorectal cancer risk.

Clinical nutrition (Edinburgh, Scotland)·2026
Same journal

Effects of early postoperative synbiotic supplementation on gastrointestinal outcomes after sleeve gastrectomy: A randomized controlled trial.

Clinical nutrition (Edinburgh, Scotland)·2026
Same journal

Association of preoperative chyme reinfusion via percutaneous endoscopic colostomy with post-reversal Fluid independence in short bowel syndrome patients with an end jejunostomy and an intact but defunctionalized colon.

Clinical nutrition (Edinburgh, Scotland)·2026
Same journal

Intradialytic nutritional intake and adherence perspective of a national and continuous meal model in a large hemodialysis patient cohort.

Clinical nutrition (Edinburgh, Scotland)·2026
Same journal

Nutritional screening within the GLIM procedure-Part 2: Operationalization of the concept risk of malnutrition using a modified Delphi procedure.

Clinical nutrition (Edinburgh, Scotland)·2026
Same journal

Nutritional screening within the GLIM procedure-Part 1: Development of a conceptual definition of risk of malnutrition using a modified Delphi procedure.

Clinical nutrition (Edinburgh, Scotland)·2026
See all related articles

Tight glycemic control is crucial for preventing microvascular complications in type 1 diabetes. For type 2 diabetes, achieving near-normal blood glucose levels is vital, requiring integrated patient and healthcare team efforts to manage risks.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Clinical Diabetes Research

Background:

  • The Diabetes Control and Complications Trial (DCCT) established the benefits of intensive glycemic control for type 1 diabetes, significantly reducing microvascular complications.
  • Current American Diabetes Association (ADA) guidelines recommend normoglycemia for type 2 diabetes, with insulin as a later treatment option after diet, exercise, and oral agents.
  • Emerging data suggest potential cardiovascular risks associated with insulin therapy in type 2 diabetes patients, a population already at elevated cardiovascular risk.

Purpose of the Study:

  • To review the established benefits of glycemic control in type 1 diabetes.
  • To discuss the current approach and emerging concerns regarding glycemic control in type 2 diabetes.
  • To highlight the need for further research into the risks, benefits, and feasibility of improved glycemic control in type 2 diabetes.

Related Experiment Videos

Main Methods:

  • Review of findings from the Diabetes Control and Complications Trial (DCCT).
  • Analysis of current American Diabetes Association (ADA) guidelines for type 2 diabetes management.
  • Evaluation of emerging long-term intervention data concerning insulin therapy in type 2 diabetes.
  • Synthesis of principles for optimizing blood glucose and managing cardiovascular risk factors.

Main Results:

  • Intensive insulin therapy in type 1 diabetes demonstrably reduces long-term microvascular complications.
  • While normoglycemia is a goal for type 2 diabetes, insulin's role is secondary, and potential cardiovascular risks require consideration.
  • Many individuals with type 2 diabetes will eventually require insulin therapy.

Conclusions:

  • Achieving blood glucose levels near normoglycemia is essential for preventing long-term microvascular complications in diabetes.
  • Type 2 diabetes is a complex condition requiring a multifaceted approach involving patient and healthcare team collaboration to optimize metabolic control and minimize cardiovascular risk.
  • Further research is necessary to fully understand the optimal strategies for glycemic control in type 2 diabetes, balancing benefits and risks.